Reactions of cyclic disulfides with carbenes; desulfurization and insertion
作者:Wataru Ando、Yorio Kumamoto、Toshikazu Takata
DOI:10.1016/s0040-4039(00)98899-3
日期:1985.1
several cyclic disulfides with carbenes generated by catalytic and photochemical decompositions of diazo compounds have been studied. Carbenes reacted with cyclic disulfides yielding 1,3-dithiane quantitatively as S-S insertion reaction, while the selective desulfurization results in the reaction of disulfides with bulky substituents. The carbene reaction is sensitive to bulkiness of disulfides.
FOEHLISCH B.; GOTTSTEIN W., LIEBIGS ANN. CHEM., 1977, NO 11, 1768-1784
作者:FOEHLISCH B.、 GOTTSTEIN W.
DOI:——
日期:——
LUHMANN U.; WENTZ F. G.; LUETTKE W.; SUESSE P., CHEM. BER. <CHBE-AM>, 1977, 110, NO 4, 1421-1431
作者:LUHMANN U.、 WENTZ F. G.、 LUETTKE W.、 SUESSE P.
DOI:——
日期:——
[EN] CYCLIC-DISULFIDE MODIFIED PHOSPHATE BASED OLIGONUCLEOTIDE PRODRUGS<br/>[FR] PROMÉDICAMENTS OLIGONUCLÉOTIDIQUES À BASE DE PHOSPHATE MODIFIÉS PAR UN DISULFURE CYCLIQUE
申请人:[en]ALNYLAM PHARMACEUTICALS, INC.
公开号:WO2022147214A2
公开(公告)日:2022-07-07
This invention relates to a compound comprising a structure of formula (I): cyclic disulfide moiety — phosphorus coupling group (I). The cyclic disulfide moiety has the structure of (C-I), (C-II), or (C-III). This invention also relates to an oligonucleotide comprising one or more compounds that comprise the structure of formula (I), wherein at least one phosphorus coupling group contains a nucleoside or oligonucleotide. The invention also relates to a pharmaceutical composition comprising the oligonucleotide described herein and a method of reducing or inhibiting the expression of a target gene by administering to the subject a therapeutically effective amount of the oligonucleotide described herein.